• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Down0.32% Nasdaq Down0.01%

    Emergent BioSolutions, Inc. (EBS)

    -NYSE
    32.83 Up 0.07(0.21%) Jul 31, 4:04PM EDT
    |After Hours : 32.83 0.00 (0.00%) Jul 31, 4:43PM EDT
    Add to Portfolio
    Income StatementGet Income Statement for:
    View: Annual Data | Quarterly DataAll numbers in thousands
    Period EndingMar 31, 2015Dec 31, 2014Sep 30, 2014Jun 30, 2014
    Total Revenue 63,633   147,975   137,954   110,325  
    Cost of Revenue18,748  32,485  32,423  34,507  
    Gross Profit 44,885   115,490   105,531   75,818  
    Operating Expenses
    Research Development38,702  38,965  44,207  37,401  
    Selling General and Administrative34,493  31,905  30,292  30,555  
    Non Recurring -   -   -   -  
    Others -   -   -   -  
    Total Operating Expenses -   -   -   -  
    Operating Income or Loss (28,310) 44,620   31,032   7,862  
    Income from Continuing Operations
    Total Other Income/Expenses Net182  862  479  1,353  
    Earnings Before Interest And Taxes(28,128)45,482  31,511  9,215  
    Interest Expense1,661  1,174  1,810  1,721  
    Income Before Tax(29,789)44,308  29,701  7,494  
    Income Tax Expense(8,269)14,192  7,869  2,465  
    Minority Interest -   -   -   -  
    Net Income From Continuing Ops(21,520)30,116  21,832  5,029  
    Non-recurring Events
    Discontinued Operations -   -   -   -  
    Extraordinary Items -   -   -   -  
    Effect Of Accounting Changes -   -   -   -  
    Other Items -   -   -   -  
    Net Income (21,520) 30,116   21,832   5,029  
    Preferred Stock And Other Adjustments -   -   -   -  
    Net Income Applicable To Common Shares (21,520) 30,116   21,832   5,029  

    Sign Up for a Free Trial to EDGAR Online Premium!
    Get the critical business and financial information you need for more than 15,000 U.S. public companies.
    Sign Up Now - Learn More

    Currency in USD.